IBD Registry in a Sub-Saharan African Population
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Ulcerative Colitis
Related studies linked through entity extraction aliases.
The Use of Web-app Constant-Care in Patients With Acute Severe Ulcerative Colitis Treated With Rescue Therapy
- Status
- UNKNOWN
- Phase
- NA
Expanded Access to Upadacitinib
- Status
- AVAILABLE
- Phase
- N/A
Osteopathy on IBS Symptoms in Patients With Ulcerative Colitis in Remission
- Status
- TERMINATED
- Phase
- NA
Comparison of Two Different Golimumab Dosing Regimens for Ulcerative Colitis
- Status
- COMPLETED
- Phase
- PHASE4
Real World Study Of The Clinical Profile And Treatment Outcomes Of Advanced Therapies For Ulcerative Colitis In Portugal
- Status
- WITHDRAWN
- Phase
- N/A
Real Life Remote Monitoring of Mild, Moderate and Severe Infectious Complications in IBD by Patient Reported Assessment
- Status
- COMPLETED
- Phase
- N/A
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Ulcerative Colitis
- Status
- WITHDRAWN
- Phase
- N/A
Diet Study on Ulcerative Colitis
- Status
- COMPLETED
- Phase
- NA
Effects of Exercise in Patients With Ulcerative Colitis
- Status
- SUSPENDED
- Phase
- NA
Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis
- Status
- UNKNOWN
- Phase
- PHASE4
Automatic Evaluation of Inflammation Activity in Ulcerative Colitis Using pCLE With Artificial Intelligence
- Status
- UNKNOWN
- Phase
- N/A
Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease.
- Status
- TERMINATED
- Phase
- PHASE4
Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis
- Status
- TERMINATED
- Phase
- PHASE2
TUDCA as a Therapy for Ulcerative Colitis (UC)
- Status
- COMPLETED
- Phase
- PHASE1
Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel Disease
- Status
- UNKNOWN
- Phase
- NA
Faecal Microbiota Transplantation in the Treatment of Chronic Pouchitis
- Status
- TERMINATED
- Phase
- NA
Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis
- Status
- WITHDRAWN
- Phase
- PHASE2
A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBD
- Status
- UNKNOWN
- Phase
- N/A
Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients
- Status
- COMPLETED
- Phase
- N/A